About this trial
This study aims to fill knowledge gaps regarding microvascular perfusion and pressor response to stress among patients with history of spontaneous coronary artery dissection (SCAD) using stress contrast echocardiography.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Adult >18 years old
Patient has a history of spontaneous coronary artery dissection (SCAD) OR patient is healthy with no significant medical history
Disqualifiers
Unable to give consent
Allergic or have a history of adverse reaction to dobutamine, the Definity® ultrasound enhancing agent, or atropine.
Has a known or suspected hypersensitivity to perflutren and therefore cannot be given Definity®.
Pregnant.
Trial population
Patients will be recruited from the clinic and community.
Trial design
Case-control
Prospective
Treatments tested in this trial
Stress Echocardiography with Contrast
Procedure/SurgeryStress Echocardiography with Contrast will be used to assess heart function and blood flow response to stressors.
Treatment groups
Trial outcomes
Primary outcomes
Change in Microvascular Function
Microvascular Function will be determined by Microvascular Blood Flow (Liters/Minute). Microvascular Blood Flow will be measured by a stress echocardiogram with contrast. A higher Microvascular Blood Flow indicated better blood flow circulation.
Change in Blood Pressure
Change is blood pressure will be measured by a stress echocardiogram with contrast (mmHg).
Change in Heart Rate
Change in heart rate will be measured by a stress echocardiogram with contrast (beats per minute).
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Mayo Clinic
Lead sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Collaborator